US LNG exports surge but will buyers in China turn up?
On Monday, Goldman Sachs updated its analysis of Fidelis Insurance Holdings (NYSE: FIHL), increasing the price target to $15.50, up from the previous $14.50, while maintaining a Sell rating on the stock. Goldman Sachs analyst Robert Cox provided insights into the decision, citing several factors influencing the firm’s outlook on Fidelis Insurance, a company currently valued at $1.94 billion. According to InvestingPro data, three analysts have recently revised their earnings estimates downward for the upcoming period, aligning with Goldman’s cautious stance.
Cox noted that despite Fidelis Insurance’s first-quarter earnings of 2025 showing promise, the firm’s Sell rating remains unchanged. This decision is based on Goldman Sachs’ earnings per share (EPS) estimates, which continue to be lower than the consensus data from Visible Alpha for the years 2025, 2026, and 2027 by 4%, 3%, and 2%, respectively. While InvestingPro analysis indicates the company is expected to be profitable this year with a forecasted EPS of $2.22, current financials show the company isn’t profitable over the last twelve months. The lower EPS forecasts are attributed to expectations of an above-market underlying loss ratio by approximately two percentage points.
The analyst highlighted concerns about the declining attractiveness of the operating environment for Fidelis Insurance, questioning the company’s long-term return on equity (ROE) guidance and the positioning of its short duration investment portfolio compared to other underwriters. These concerns are particularly notable given the company’s impressive 23.93% revenue growth in the last twelve months. Despite these concerns, Cox acknowledged an increase in EPS estimates by an average of 2.5% for the years 2025 to 2027, driven by stronger than anticipated net premium written (NPW) growth in the first quarter of 2025. For deeper insights into Fidelis Insurance’s financial health and growth prospects, investors can access the comprehensive Pro Research Report available on InvestingPro.
However, this positive adjustment was somewhat tempered by a revised outlook for net investment income, which is expected to be lower due to current quarter losses impacting invested assets more significantly than initially forecasted.
The revised price target of $15.50 reflects a 7% increase from the prior target and is based on a projected total return opportunity of negative 9%. This update follows Goldman Sachs’ comprehensive review of Fidelis Insurance’s recent financial performance and market conditions.
In other recent news, Fidelis Insurance Holdings Ltd reported strong financial results for the fourth quarter of 2024, surpassing both earnings and revenue forecasts. The company achieved earnings per share of $0.98, exceeding the expected $0.82, and reported revenue of $953.7 million, significantly higher than the forecasted $534.84 million. Fidelis experienced a 23% growth in gross premiums written, totaling $4.4 billion. The company maintained a combined ratio of 99.7% and returned $152 million to shareholders through dividends and share repurchases.
Analysts have adjusted their outlook on Fidelis, with Jefferies raising its price target to $17 while maintaining a Hold rating, and Citizens JMP increasing its target to $27 with a Market Outperform rating. These adjustments reflect confidence in Fidelis’ ability to capitalize on favorable market conditions, despite challenges in the aviation sector and anticipated losses from California wildfires. S&P Global Ratings revised its outlook for Fidelis from positive to stable, citing aviation-related losses and wildfire impacts, though it affirmed the company’s credit ratings.
Additionally, Fidelis announced its Annual General Meeting of Shareholders, scheduled for May 6, 2025, where key governance matters will be discussed. Despite the challenges, Fidelis’ strong capital position and strategic initiatives are expected to support continued growth and resilience in the evolving market landscape.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.